Prometheus Biosciences, Inc. RXDX
Set alert
199.92 0.00 0.00%
At close · Jun 15
199.92 Day range 199.96
52-week range unavailable
- Open
- 199.68
- Prev close
- 199.92
- Mkt cap
- 9.56B
- Vol
- 1.79M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 199.92
- High
- 199.96
- Forward P/E
- -44.33
- Beta
- -0.49
- Short ratio
- 3.97
- Inst. own
- 81.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 10, 2023
- 50-d avg
- 189.46
- 200-d avg
- 112.93
- 1y target
- 190.00
Ownership
Held by insiders 16.61%
Held by institutions 81.01%
Float held by institutions 97.15%
Institutions 311
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 6.84% | 3,272,104 | 654.16M | Mar 30, 2023 |
| Blackrock Inc. | 5.86% | 2,799,818 | 559.74M | Mar 30, 2023 |
| Vanguard Group, Inc. (The) | 5.68% | 2,716,901 | 543.16M | Mar 30, 2023 |
| Boxer Capital, LLC | 3.97% | 1,897,500 | 379.35M | Mar 30, 2023 |
| 72 Investment Holdings, LLC | 3.87% | 1,848,024 | 369.46M | Mar 30, 2023 |
| Cormorant Asset Management, LP | 3.46% | 1,655,000 | 330.87M | Mar 30, 2023 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.23% | 1,060,681 | 212.05M | Dec 30, 2022 |
| Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 1.75% | 832,938 | 166.52M | Dec 30, 2022 |
| iShares Russell 2000 ETF | 1.61% | 765,275 | 152.99M | Feb 27, 2023 |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.32% | 625,964 | 125.14M | Feb 27, 2023 |
| Vanguard Extended Market Index Fund | 0.98% | 465,623 | 93.09M | Dec 30, 2022 |
| Fidelity Select Portfolios - Biotechnology | 0.84% | 397,555 | 79.48M | Feb 27, 2023 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADAMS HELEN C | Director | Stock Award(Grant) | May 18, 2023 | 2,674 |
| CEDARS SINAI INTELLECTUAL PROPERTY CO | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 7, 2023 | 0 |
| HASSAN FRED | Director | Stock Award(Grant) | May 18, 2023 | 2,123 |
| HENDRIX MARTIN | Director | Stock Award(Grant) | May 18, 2023 | 2,071 |
| LAUR JAMES | Director | Stock Award(Grant) | May 18, 2023 | 2,071 |
| MARSHALL KEITH W. | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 1, 2023 | 87,973 |